A study of the efficacy of curcumin based drugs for the treatment of Glioblastoma

dc.contributor.author	Chowdhury, Kanwal
dc.date.accessioned	2022-04-06T14:13:31Z
dc.date.available	2022-04-06T14:13:31Z
dc.date.issued	2018
dc.identifier.uri	https://cache.kzoo.edu/handle/10920/43363
dc.description	1 Broadside. 48"W x 36"H	en_US
dc.description.abstract	The purpose this study was to test the efficacy of Curcumin- CD and Curcumin-CD-F127, two synthesized drugs that were designed to make curcumin water soluble. Using an MTT Assay, Curcumin-CD and Curcumin-CD-F127 were tested on two human cell lines, U-251 and NS-1. The cells were exposed to three different concentrations for both drugs: 10 mg/ml, 5 mg/ml, and 2.5 mg/ml. After completing the study, it was found that the drugs were effective against glioblastoma, but only at the higher concentrations.	en_US
dc.description.sponsorship	Kalamazoo College. Department of Biology. Diebold Symposium, 2018	en_US
dc.format.mimetype	application/pdf
dc.language.iso	en_US	en_US
dc.publisher	Kalamazoo, Mich. : Kalamazoo College	en_US
dc.relation.ispartof	Kalamazoo College Diebold Symposium Presentation Collection	en
dc.rights	U.S. copyright laws protect this material. Commercial use or distribution of this material is not permitted without prior written permission of the copyright holder.	en
dc.title	A study of the efficacy of curcumin based drugs for the treatment of Glioblastoma	en_US
dc.type	Presentation	en_US

Diebold Symposium Posters and Schedules [479]
Poster and oral presentations by senior biology majors that include the results of their Senior Integrated Projects (SIPs) at the Diebold Symposium. Abstracts are generally available to the public, but PDF files are available only to current Kalamazoo College students, faculty, and staff.